Literature DB >> 32616604

Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey.

Marlene Plüß1, Gamal Chehab2, Peter Korsten3.   

Abstract

Entities:  

Keywords:  epidemiology; hydroxychloroquine; lupus erythematosus, systemic

Mesh：

Substances：

Year:  2020        PMID： 32616604     DOI： 10.1136/annrheumdis-2020-217967

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.

Authors:  Ruth Fernandez-Ruiz; Jacqueline L Paredes; Timothy B Niewold
Journal:  Transl Res       Date:  2020-12-19       Impact factor: 7.012

2.  Challenges of Egyptian patients with systemic lupus erythematosus during the COVID-19 pandemic.

Authors:  Samar Tharwat; Sherin Zohdy Mohamed; Mohammed Kamal Nassar
Journal:  Reumatologia       Date:  2021-08-20

3.  COVID-19 in patients with systemic lupus erythematosus: A systematic review.

Authors:  Xue-Lei Fu; Yan Qian; Xiao-Hong Jin; Hai-Rong Yu; Lin Du; Hua Wu; Hong-Lin Chen; Ya-Qin Shi
Journal:  Lupus       Date:  2022-04-05       Impact factor: 2.858

Review 4.  Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.

Authors:  Rashmi R Shah
Journal:  J Clin Pharm Ther       Date:  2020-09-27       Impact factor: 2.145
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.